Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nurix Therapeutics (NRIX) Change in Taxes (2020 - 2021)

Nurix Therapeutics (NRIX) has disclosed Change in Taxes for 2 consecutive years, with -$2.9 million as the latest value for Q3 2021.

  • Quarterly Change in Taxes rose 81.33% to -$2.9 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was -$3.6 million through Nov 2021, changed N/A year-over-year, with the annual reading at -$3.6 million for FY2021, 194.7% down from the prior year.
  • Change in Taxes for Q3 2021 was -$2.9 million at Nurix Therapeutics, down from -$839000.0 in the prior quarter.
  • The five-year high for Change in Taxes was $135000.0 in Q1 2021, with the low at -$15.7 million in Q3 2020.